Pradeepa Yoganathan, MD
Ophthalmology · Detroit, MINPI 1104137728
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $94,032 of the $115,382 with a category attached, or 81.5%. Hoffmann-la Roche Limited accounts for 81.0% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $26,652, 3.3 times the $8,021 reported in 2019. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $1311.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hoffmann-la Roche Limited$93K
- Alimera Sciences, Inc.$13K
- Apotex Inc.$5K
- ANI Pharmaceuticals, Inc.$2K
- Cardinal Health 108 LLC$2K
- Apellis Pharmaceuticals, Inc.$213
- plus $818 from 12 others
Across 3 payments — averaging $2987.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ANI Pharmaceuticals, Inc.$6K
- Alimera Sciences, Inc.$3K
What the payments were for
- Consulting fees$94,03281%
- Speaking & faculty fees$10,6389%
- Grants$6791%
- Travel & lodging$7,5817%
- Food & beverage$2,4332%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hoffmann-la Roche Limited | 43 | $93,437 |
| Alimera Sciences, Inc. | 17 | $12,835 |
| Apotex Inc. | 2 | $4,803 |
| ANI Pharmaceuticals, Inc. | 2 | $1,700 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| Apellis Pharmaceuticals, Inc. | 4 | $213 |
| Carl Zeiss Meditec, Inc. | 1 | $206 |
| Regeneron | 1 | $143 |
| Regeneron Healthcare Solutions, Inc. | 5 | $138 |
| Harrow Eye, LLC | 1 | $125 |
| Astellas Pharma US Inc | 2 | $48 |
| Genentech USA, Inc. | 3 | $44 |
| Mallinckrodt Enterprises LLC | 1 | $21 |
| Oculus Surgical Inc. | 1 | $20 |
| Dompe US, Inc. | 1 | $20 |
| Alcon | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Beaver-visitec International, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$115,382 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 19 | $2,974 |
| Bromfenac Sodium | 12 | $2,933 |
| Difluprednate | 19 | $1,594 |
| Prednisolone Acetate | 33 | $1,318 |
| Latanoprost | 23 | $184 |
| Prednisone | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Detroit
- Bret HughesDetroit$123K
- Michael ColemanDetroit$20K
- Daniel ZuckerbrodDetroit$16K
- Daniel AppleDetroit$10K
- Gabriel SosneDetroit$9K
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.